Sternal Closure Bone Cement Market size was valued at USD 0.45 Billion in 2022 and is projected to reach USD 0.78 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The Europe sternal closure bone cement market is a rapidly growing segment within the broader medical device and surgical instrument industry. Sternal closure bone cement is used primarily in patients undergoing surgeries that require sternotomy procedures, which involve the surgical division of the sternum to access the heart or other thoracic organs. These cements are designed to securely reattach the sternum post-surgery, preventing complications such as instability or infection and ensuring proper healing. The market is expected to grow due to the increasing prevalence of cardiovascular diseases, rising number of thoracic surgeries, and advancements in surgical techniques and materials used in bone cement formulations. Additionally, the growing aging population across Europe, which results in an increased need for surgical interventions, further drives market demand.
Download In depth Research Report of Sternal Closure Bone Cement Market
Median sternotomy is the most common surgical procedure involving sternal closure. It is performed in a wide range of thoracic surgeries, most notably in open-heart surgeries, such as coronary artery bypass grafting (CABG) and heart valve replacements. The median sternotomy involves a vertical incision along the midline of the chest, followed by the separation of the sternum to provide access to the heart. After the surgery, sternal closure bone cement is used to reattach the two halves of the sternum, ensuring stability and promoting proper healing. Given its importance in various cardiac surgeries, the demand for sternal closure bone cement used in median sternotomy is high, contributing significantly to the market's overall growth. As the number of cardiovascular surgeries continues to rise, particularly in aging populations, the need for robust and reliable closure solutions increases in parallel.
Advancements in the quality of sternal closure bone cements have led to improved patient outcomes post-surgery. Stronger and more biocompatible cements are now being developed to reduce complications such as infections, sternal instability, and chronic pain. These cements provide better mechanical properties, supporting faster and more secure recovery. Furthermore, with the rise in minimally invasive cardiac procedures and the growing use of robotic-assisted surgeries, the use of sternal closure bone cement in median sternotomy applications is becoming more widespread. This trend is further fueled by the demand for high-performance, long-lasting closure solutions that enhance patient recovery times and overall success rates of cardiac procedures.
Hemisternotomy is a less invasive alternative to the median sternotomy, where only one half of the sternum is divided to access the heart or lungs. This procedure is commonly performed in surgeries that involve the right side of the heart or the lungs, such as lung resections or certain heart valve surgeries. The advantage of a hemisternotomy is that it involves less tissue disruption compared to a full median sternotomy, leading to a quicker recovery and less postoperative pain for the patient. However, after the surgical intervention, proper sternal closure is essential to avoid complications such as sternal instability or malunion, making the use of sternal closure bone cement critical in these procedures. The growing preference for less invasive techniques in thoracic surgery is driving demand for sternal closure products specifically designed for hemisternotomy applications.
The sternal closure bone cement used in hemisternotomy applications must provide strong bonding capabilities and support the healing process while accommodating the anatomical differences compared to median sternotomy. Innovations in materials and techniques continue to evolve, allowing for the development of cements that offer improved flexibility and strength. These advancements not only contribute to faster recovery times but also reduce the risk of complications such as sternal nonunion and wound infections. With the increasing adoption of hemisternotomy for specific thoracic procedures, the demand for specialized bone cements is expected to continue growing, creating significant opportunities in the European market.
Bilateral thoracosternotomy is a more complex surgical approach that involves dividing both sides of the sternum to gain access to both the heart and lungs. This technique is typically used in more extensive surgeries, such as those involving both heart and lung transplants or major heart valve repairs. The procedure allows surgeons to access both the left and right sides of the thoracic cavity with greater ease, making it an ideal approach for highly complex cardiac and thoracic surgeries. After the surgical procedure, sternal closure bone cement is used to securely reattach the sternum, helping to ensure proper healing and preventing complications related to sternal instability. The use of bone cement in bilateral thoracosternotomy applications requires highly durable and efficient products to meet the challenges posed by the extensive nature of the procedure.
In bilateral thoracosternotomy, the requirements for sternal closure bone cement are particularly demanding due to the larger surgical incision and the increased risk of complications related to sternal separation. Innovations in cement formulation and delivery methods are focused on improving the biomechanical properties of the cements, providing stronger, more flexible, and faster-setting solutions. These advancements not only improve surgical outcomes but also enhance patient recovery by reducing the risk of postoperative complications such as sternal dehiscence or nonunion. As bilateral thoracosternotomy becomes more common in highly specialized surgeries, the need for reliable, high-performance sternal closure bone cements is expected to drive market growth in Europe.
One of the key trends in the European sternal closure bone cement market is the growing demand for minimally invasive surgery. As surgical techniques evolve to reduce patient trauma and recovery times, the market for bone cement products has adapted to meet the needs of less invasive procedures. Innovations in sternal closure solutions are focused on providing better outcomes for patients undergoing these procedures, with an emphasis on improving the strength, flexibility, and speed of cement setting. Furthermore, advancements in biocompatible materials have led to more effective bone cements, which not only promote healing but also reduce the risk of infection and complications.
Another significant trend is the increasing number of thoracic surgeries performed in Europe due to the rising prevalence of cardiovascular diseases, aging populations, and growing awareness of surgical interventions. As the number of heart surgeries and lung procedures rises, the demand for effective sternal closure solutions is increasing. The trend is further supported by the development of new technologies and materials in the field of sternal closure bone cements, making them safer, more durable, and more suitable for a range of thoracic surgeries.
The European sternal closure bone cement market presents numerous opportunities for growth, particularly in light of ongoing advancements in surgical techniques. One of the primary opportunities lies in the growing adoption of minimally invasive surgeries, which require specialized sternal closure products. Companies focusing on the development of high-performance, biocompatible, and easy-to-use bone cement solutions stand to capture significant market share. Additionally, with the increasing prevalence of heart disease and thoracic conditions, the demand for effective and reliable sternal closure products is expected to continue growing. Expanding product offerings and partnerships with leading hospitals and surgical centers also present promising growth opportunities for companies operating in the market.
Another opportunity lies in the aging population across Europe, which is expected to increase the number of surgeries related to cardiovascular diseases, heart failure, and lung diseases. Companies that can innovate to create cements that are specifically designed for complex surgeries, such as bilateral thoracosternotomy, will be well-positioned to benefit from this expanding market. With healthcare policies and advancements in surgical practices favoring the use of high-quality, dependable sternal closure bone cement, there are significant prospects for businesses to contribute to improved patient outcomes while capitalizing on market demand.
What is sternal closure bone cement used for?
Sternal closure bone cement is used to reattach the sternum after thoracic surgeries like heart surgery or lung surgery.
How does sternal closure bone cement improve recovery?
The cement helps stabilize the sternum after surgery, reducing the risk of complications and promoting faster healing.
Is there a specific cement for heart surgeries?
Yes, there are specially formulated cements designed for the stability and healing requirements of heart surgeries.
What are the benefits of using bone cement in hemisternotomy?
Bone cement in hemisternotomy ensures proper sternal closure, improving stability and reducing recovery time.
What are the risks associated with sternal closure bone cement?
The main risks include infection, sternal instability, or complications related to the body’s reaction to the material.
Is minimally invasive surgery increasing the demand for bone cement?
Yes, as minimally invasive surgeries grow in popularity, the demand for bone cement designed for these procedures is also increasing.
How does the aging population affect the sternal closure bone cement market?
An aging population leads to more cardiovascular and thoracic surgeries, driving demand for reliable sternal closure products.
What materials are commonly used in sternal closure bone cements?
Materials like acrylic-based compounds and calcium phosphate are commonly used in sternal closure bone cements for their strength and biocompatibility.
Can sternal closure bone cement reduce post-surgical pain?
Yes, by providing strong fixation of the sternum, bone cement can help minimize complications and reduce pain during recovery.
What advancements are being made in sternal closure bone cement technology?
Advancements include improving cement strength, flexibility, and biocompatibility, as well as faster-setting formulations for enhanced recovery.
```
Top Sternal Closure Bone Cement Market Companies
DePuy Synthes (US)
Zimmer Biomet Holdings (US)
A&E Medical (US)
KLS Martin Group (US)
Orthofix International N.V. (US)
ABYRX (US)
Acute Innovations (US)
Kinamed Incrporated (US)
Praesidia Srl (Italy)
IDEAR S.R.L. (Argentina)
Regional Analysis of Sternal Closure Bone Cement Market
Europe (Germany, United Kingdom, France, Italy, and Spain, etc.)
For More Information or Query, Visit @ Sternal Closure Bone Cement Market Insights Size And Forecast